'Gelzempic' Could Make Popular Weight Loss Drugs Easier to Take

One of the most popular drugs in recent history could someday become less of a hassle to use. In new research presented Saturday, scientists in France have unveiled a novel hydrogel version of semaglutide, the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy. The slow-releasing version should allow people to only need a monthly injection of these drugs, rather than once-a-week as currently required, the scientists say. The research was conducted by scientists at the France-based biotech company Adocia, as part of the company’s overarching goal...